
==== Front
Graefes Arch Clin Exp Ophthalmol
Graefes Arch Clin Exp Ophthalmol
Graefe's Archive for Clinical and Experimental Ophthalmology
0721-832X
1435-702X
Springer Berlin Heidelberg Berlin/Heidelberg

38587655
6465
10.1007/s00417-024-06465-2
Retinal Disorders
The time course of spontaneous closure of idiopathic full-thickness macular holes
http://orcid.org/0000-0002-4120-534X
Neubauer Jonas StudyJN@Outlook.com

1
Gelisken Faik 1
Ozturk Taylan 2
Bartz-Schmidt Karl-Ulrich 1
Dimopoulos Spyridon 1
1 https://ror.org/03a1kwz48 grid.10392.39 0000 0001 2190 1447 Department of Ophthalmology, Eberhard Karls University, Elfriede-Aulhorn-Straße 7, 72076 Tuebingen, Germany
2 https://ror.org/00dbd8b73 grid.21200.31 0000 0001 2183 9022 Department of Ophthalmology, Dokuz Eylul University, Izmir, Turkey
8 4 2024
8 4 2024
2024
262 9 28592865
6 12 2023
13 3 2024
27 3 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Abstract 

Purpose

Spontaneous closure of idiopathic full-thickness macular holes (iFTMH) has been reported regularly. However, little is known about its probability and timeline.

Methods

In this retrospective study all consecutive patients who presented between August 2008 and August 2019 were screened for the presence of a macular hole and only iFTMHs were included. The primary outcome measure was the spontaneous closure of the iFTMH.

Results

Of 1256 eyes with macular holes, 338 fulfilled the inclusion criteria. Spontaneous closure of the iFTMH was detected in 31 eyes (9.2%) with a median time of 44 days after diagnosis. Eyes exhibiting spontaneous closure demonstrated a higher baseline best-corrected visual-acuity (BCVA) and smaller iFTMH diameter (p < 0.0001 and p < 0.0001, respectively). The mean BCVA improved from 0.4 logMAR (SD ± 0.21) to 0.29 logMAR (SD ± 0.20) after spontaneous closure (p = 0.031). The iFTMH diameter was positively correlated with the time to spontaneous closure (Pearson-r = 0.37, p = 0.0377). Spontaneously closed iFTMHs reopened in 16% (n = 5) of cases, with a median of 136 days after closure. A logistic regression model showed the hole diameter was associated with spontaneous closure (odds-Ratio 0.97, 95%CI [0.96, 0.98]). The Kaplan–Meier-Curve revealed that approximately 25% of small-iFTMH (n = 124) and 55% of iFTMH with a diameter < 150µm (n = 48) closed spontaneously within two months.

Conclusion

The established gold-standard for the treatment of iFTMHs is macular surgery. However, the potential for spontaneous closure of small iFTMHs must be acknowledged. Therefore, if surgical treatment is delayed in individual cases, close observation is recommended.

Keywords

Macular Hole
Full Thickness Macular Hole
Spontaneous Closure
Time Course
Re-opening
Watch and Wait
issue-copyright-statement© Springer-Verlag GmbH Germany, part of Springer Nature 2024
==== Body
pmc

Introduction

An idiopathic full-thickness macular hole (iFTMH) is a vitreomacular interface disease with an opening of all neurosensory retinal layers in the fovea, leading to vision loss, metamorphopsia and central scotoma. It is more frequently observed in women over the age of 65, with an incidence of about eight eyes per 100,000 per annum [1]. Following the report of the first surgical closure of iFTMHs by Kelly and Wendell, advanced vitreoretinal surgical techniques contributed to successful postoperative restoration of the foveal microstructure with improvement of the vision [2–7]. There have been also efforts to achieve closure of iFTMH by intravitreal pharmacotherapy, which resulted in a favorable outcome in selected cases [8]. Currently, the first-line therapy for the iFTMH is macular surgery.

Although the macular surgery is a safe and effective, spontaneous closure of iFTMHs has been reported repeatedly over the years [9–13]. Before the introduction of Optical Coherence Tomography (OCT), spontaneous closure of iFTMHs was described in several studies, ranging from 0% to 15.8% [14–16]. However, given the difficulty of diagnosing small iFTMHs by funduscopy, these studies are subject to possible bias. To our knowledge, few studies have investigated the spontaneous closure of iFTMH using OCT imaging [17–19].

While the aforementioned reports focused on the rates of spontaneous closure, the dynamics of this phenomenon are also critical, as delayed surgery is associated with poor prognosis [20, 21]. Therefore, the aim of this study was to investigate the factors related to the spontaneous closure and the time course of this phenomenon in particular.

Methods

We retrospectively reviewed the electronical medical charts of all patients presenting between August 2008 and August 2019 at the Department of Ophthalmology of the University of Tuebingen and included 1256 eyes diagnosed with an iFTMH. All patients underwent complete ophthalmologic examination, including best-corrected visual acuity (BCVA), slit-lamp biomicroscopy and dilated funduscopic evaluation. Spectral domain OCT (Heidelberg Engineering GmbH, Heidelberg, Germany) was performed at the first presentation and in all follow-up examinations. Patients received a volume scan (25 cross sections with a distance of 61 µm) and six or 12 radial scans. The primary outcome measure was a spontaneous closure of the iFTMH detected on OCT imaging. Inclusion criteria were: 1- Available SD-OCT at the first presentation and follow-up examinations; 2- SD-OCT examination one day before the scheduled macular surgery. Exclusion criteria were: 1- Previous intravitreal pharmacotherapy; 2- Ocular diseases that could interfere with morphology of the macula or the visual prognosis; 3- Ocular trauma; 4- Previous vitreoretinal surgery, laser photocoagulation or cryosurgery; 5- Myopia of less than minus six diopters (< -6 Diopters); 6- Missed OCT-examination or poor image quality; 7- Secondary full-thickness macular holes. The diagnosis of an iFTMH was based on the OCT imaging and the classification by the International Vitreomacular Traction Study (IVTS) Group was used for grading [22]. The iFTMH diameter was determined by measuring the smallest distance at the mid-retina on the selected OCT scan that captured the widest cross-sectional image of the macular hole [22]. To ensure the reliability of the measurements, 30 eyes were randomly selected, and the diameter of the iFTMH was measured by a second ophthalmologist without revealing the value of the first measurement, resulting in an excellent intraclass correlation of 0.95. The presence of vitreomacular traction and epiretinal membrane was documented. Patients were informed about the natural course and therapy options, including close observation in case of a small iFTMH and good baseline BCVA, intravitreal pharmacotherapy in selected cases, and vitrectomy with macular surgery. The surgery was scheduled as soon as possible, and the OCT examination was repeated on the day before the surgery. For the creation of Kaplan–Meier curves all available data were considered. In the absence of spontaneous closure, the last OCT scan with an iFTMH was noted as the date of censoring.

The iFTMHs were graded as proposed by the International Vitreomacular Traction Study Group (IVTS) in small (≤ 250 µm), medium (251-400 µm) and large (> 400 µm) iFTMHs and depending on the presence/absence of vitreofoveal traction [22]. Visual acuity was analyzed using logMAR. Statistical analysis was performed using R and Prism 6, GraphPad. The D'Agostino and Pearson omnibus normality test, Fisher’s test, Chi-square test with Yates’ correction and Mann–Whitney U test were used and statistical significance was assumed for p < 0.05. This study was performed according to the principles of the Declaration of Helsinki and it was approved by the Ethics Committee of the University of Tuebingen (Project Number 215/2020BO2).

Results

Of the total 1256 eyes with iFTMH, 338 fulfilled the inclusion criteria. A total of 918 eyes were excluded (549 eyes with previous intraocular surgery or associated macular diseases, 360 eyes without OCT examination and nine eyes with low-quality of the OCTs). The study cohort comprised 338 eyes of 324 patients (199 women) with a mean age of 68.9 years (range 40 – 90 years). Bilateral involvement was observed in 14 patients (4.1%) at the first visit or during the follow-up period. The time interval between the diagnosis and surgery was in median 34 days (range 4–618). Of the patients without spontaneous closure (n = 307), 279 (90.9%) agreed to have surgery. A total of 28 patients (28 eyes, 9.1%) refused surgery. The median follow-up time of these patients was 149 days (range 16–1849). In the spontaneous closure group, two out of 31 patients refused surgery. No significant difference was found between the two groups regarding surgery refusal (p = 1). Table 1 summarizes the baseline characteristics of the study population.Table 1 Baseline characteristics of the study population

	No Spontaneous Closure (n = 307)	Spontaneous Closure (n = 31)		
Age, mean	69,11 (SD 7,98) (range, 40–89 years)	66,77 (SD 9,24) (range, 54–90 years)	p = 0.131	
Sex	184 female (60%)	15 female (48%)	p = 0.252	
	123 male (40%)	16 male (52%)		
Lens		
  Phakic	223 (73%)	23 (74%)	p = 12	
  Pseudophakic	84 (27%)	8 (26%)		
BCVA Baseline (mean)	0.68 (SD 0.27)	0.40 (SD 0.21)	p < 0.00013	
Gass Classification		
  2	94 (31%)	31 (100%)		
  3	70 (23%)	-		
  4	142 (46%)	-		
IVTS Classification*				
  Small without VMT	62 (20%)	17 (55%)		
  Small with VMT	31 (10%)	14 (45%)		
  Medium without VMT	75 (24%)	-		
  Medium with VMT	39 (13%)	-		
  Large without VMT	78 (25%)	-		
  Large with VMT	22 (7%)	-		
Vitreomacular Traction		
  No	215 (70%)	17 (55%)	p = 0.102	
  Yes	92 (30%)	14 (45%)		
Epiretinal Membrane		
  No	224 (73%)	20 (65%)	p = 0.402	
  Yes	83 (27%)	11 (35%)		
Mean Diameter (µm)	345,6 (SD 161,6)	98,9 (SD 58,32)	p < 0,00013	
Median Time to Spontaneous Closure (days)		44 (range, 5–1013)		
BCVA: Best-corrected visual acuity

VMT: Vitreo-macular traction

SD: Standard deviation

1 Unpaired t-test (with D'Agostino & Pearson Omnibus normality test)

2 Fisher's exact test

3 Wilcoxon-Mann–Whitney-Test

* IVTS Classification: Small ≤ 250 μm, Medium > 250 μm and ≤ 400 μm, Large > 400 μm

Spontaneous closure of the iFTMH was detected in 31 eyes (9.2%) of 30 patients with a median time of 44 days (range 5–1013) after diagnosing the iFTMH. One patient showed spontaneous closure in both eyes. No significant differences were observed in terms of diameter or time to spontaneous closure between patients with and without vitreomacular traction (p = 0.40 and p = 0.55, respectively). Eyes with spontaneous closure had a higher baseline BCVA and smaller iFTMH diameter (p < 0.0001 and p < 0.0001, respectively), and there was no statistically significant difference in age, gender, lens status, frequency of vitreofoveal traction or the presence of an epiretinal membrane (p = 0.13, p = 0.25, p = 1, p = 0.10 and p = 0.40, respectively). The mean BCVA improved significantly from 0.4 logMAR (SD ± 0.21) to 0.29 logMAR (SD ± 0.20) after spontaneous closure (p = 0.031). In eyes with spontaneous closure, the diameter of the iFTMH was positively correlated with the time to spontaneous closure (Pearson r = 0.37, p = 0.0377) (Fig. 1).Fig. 1 Semi-logarithmic regression of idiopathic full-thickness macular hole (iFTMH) diameter and the time to spontaneous closure (n = 31). A smaller iFTMH diameter was significantly correlated with a shorter time to spontaneous closure (Pearson r = 0.37, p = 0.0377)

In the logistic regression analysis of age, baseline BCVA, lens status, status of vitreofoveal traction and iFTMH diameter, only the diameter [µm] was found to be significantly associated with spontaneous closure (odds Ratio 0.97, 95%CI [0.96, 0.98]). The mean diameter of the spontaneously closed iFTHM was 98.9 µm (range 30-249 µm), corresponding to a small iFTMH. The median follow-up after spontaneous closure (available for 23 patients, 74.1%) was 406 days (range 21 to 4161 days). A re-opening of the spontaneous closed iFTMH was found in five eyes (16.1%) after a median of 136 days after closure (range 23 to 708 days).

Since spontaneous closure was observed in eyes with small iFTMHs (n = 124), we plotted this data on a Kaplan–Meier curve and found that approximately 25% of the iFTMHs closed spontaneously within two months. For a diameter of < 150 µm (n = 48), the frequency of the spontaneous closure increased to 55% of eyes within that time period (Fig. 2).Fig. 2 Kaplan–Meier-Plot of spontaneous closure. Upward blips represent censored patients. a Approximately 25% of idiopathic full-thickness macular holes (iFTMH) with a diameter ≤ 250 µm (n = 124) close spontaneously within two months of diagnosis. b 55% of iFTMHs with a diameter ≤ 149 µm (n = 48) close spontaneously within two months of diagnosis

Discussion

The study included 338 eyes with iFTMHs and revealed a spontaneous closure rate of 9.2% at a median of 44 days after the diagnosis. All eyes with spontaneous improvement had small iFTMHs.

Previous retrospective studies using OCT imaging for iFTMH diagnosis reported spontaneous closure in 2,7–3,5% of eyes, while the mean time to spontaneous closure were 2, 2.5, and 5 months [17–19]. The time to closure was similar in our large cohort, however, we found a higher rate of spontaneous closure (9.2%). This discrepancy may be explained by the different study populations. In our study, eyes with spontaneous closure had an average hole diameter of 98.9 µm, which was smaller compared to 201 µm, 195 µm and 162 µm found in previous studies. This might suggest that patients with smaller iFTMH are underrepresented in the other studies, leading to a lower spontaneous closure rate.

One of the prospective studies investigating the effect of ocriplasmin in eyes with vitreomacular traction or iFTMH found in the control group a spontaneous closure rate of 15.4% (4/26 eyes with iFTMH) at month three without re-opening in the 24-month follow-up period [8, 23, 24].

In our study population, spontaneous closure was found only in eyes with small iFTMHs, whereas in the mentioned retrospective studies, few eyes had diameters greater than 250 µm [17–19]. Smaller iFTMHs have been reported to have a higher likelihood of spontaneous closure. Our study found a significant correlation between hole diameter and spontaneous closure.

There are also reports regarding the spontaneous re-opening between three months and three years after achieving complete iFTMH closure with or without surgical intervention [10, 25–27]. In our study population, we found re-opening of spontaneously closed iFTMH in five patients with a median of 4 months after closure. Considering the relatively short time span until reopening, the continuation of the regular follow-up examinations is important. In our clinic, patients were advised to have follow-up examinations at 2-week intervals for 6 weeks after the initial diagnosis. Subsequently, ophthalmological examinations were performed alternately with local ophthalmologists at four-week intervals, provided an OCT examination was available. As all patients in our study had full health insurance, it is unlikely that any missed follow-up examinations were due to monetary reasons. Although we cannot be certain, we assume that patients were referred if any morphological or functional worsening was noticed by the local ophthalmologists. All patients with a re-opening after spontaneous closure underwent macular surgery and showed closure of the iFTMH. Due to the small number of observed re-opened iFTMHs, further statistical analysis of OCT features was not feasible. In the aforementioned retrospective studies and the prospective OASIS study, only one re-opening was described which might be due to the lower number of observed spontaneous closed iFTMHs compared to our study [17–19, 23, 25, 28].

The exact mechanism of spontaneous closure of iFTMH remains unknown. One explanation is that the release of vitreous traction leads to decreased vertical forces and to a flattening and convergence of the hole edges [29]. However, since the proportion of eyes with and without vitreofoveal traction was comparable in both groups (30% in the no spontaneous closure group, and 45% in the spontaneous closure group, p = 0.103), other mechanisms should also be considered. Furthermore, closure of the iFTMH with persistent vitreofoveal traction is also reported [18]. Consequently, we would consider the release of vitreofoveal traction favorable for spontaneous closure, although this cannot be generalized for all cases with vitreofoveal traction.

Interestingly, in case reports of secondary full-thickness macular holes associated with cystoid macular edema in uveitis, ocular trauma, post-laser inflammation, or Irvine-Gass syndrome, the resolution of the intraretinal pseudocysts is thought to have contributed to spontaneous closure [10, 26, 30–36].

The formation of a bridge-like structure at the edges of the hole is thought to be a reparative reaction of the Müller cells preceding the spontaneous closure [37–39]. In line with these reports, many eyes with spontaneous closure in our study presented with a bridging phenomenon in the OCT (Fig. 3).Fig. 3 Spontaneous closure of an idiopathic full-thickness macular hole with bridging phenomenon in a 57-year-old lady 52 days after diagnosis

So far, limited information is known about the time course of spontaneous closure of the small iFTMHs. Based on the data presented, approximately 25% of small iFTMHs (diameter ≤ 250 µm) and around 50% of iFTMHs with diameters < 150 µm can close spontaneously within two months of diagnosis. Therefore, in patients with small iFTMHs and relatively good vision a „watchful waiting" approach with short follow-up regime may be offered to some patients after careful considerations of all circumstances. However, a recent meta-analysis estimated a minor vision loss of 0.008 logMAR per month of additional waiting for surgery [20]. As this study included iFTMHs of all sizes, and small iFTMHs have a higher surgical success rate, extrapolating the degree of vision loss for small iFTMHs only is difficult [20, 21].

One of the main limitations of this study is its retrospective study design. However, we believe that our analysis is rather underestimating spontaneous closure rates because patients with spontaneous BCVA improvement may not seek ophthalmological examination in the first place or are more likely to miss follow-up appointments. Moreover, the time of the iFTMH closure is likely overestimated, as spontaneous closure was diagnosed on the day of the OCT examination and not at the time of subjective BCVA improvement. However, it is notable that the time of diagnosis based on the OCT examination is not the time at which the iFTMH actually develops. An alternative to our approach is using the onset of symptoms as the time of diagnosis. Nevertheless, we have decided against this, as not all patients are able to state the onset of symptoms precisely enough (e.g. if the healthy partner eye is dominant). Therefore, caution should be applied when generalizing these results.

In summary, this study revealed spontaneous closure of small iFTMHs in a relatively high percentage of patients within two months of diagnosis in our cohort. Considering that the established standard therapy for iFTHMs is a surgical approach, this information could be relevant to clinical practice and future studies. While our data cannot be used to predict the course of an individual patient's disease with high accuracy, future investigations are required to validate the conclusions drawn from this study and to help establish validated treatment recommendations for patients with small iFTMHs in the clinical routine.

Acknowledgements

We would like to thank Dr. Gunnar Blumenstock, Institute for Clinical Epidemiology and Applied Biometry, Eberhard Karls University Tuebingen, for statistical advice on this project.

Author contribution

Conceptualization & methodology, All; investigation & data curation, J.N., F.G., T.Ö.; writing—original draft preparation, J.N.; writing—review and editing, all; visualization, J.N.; supervision, J.N., F.G.; All authors have read and agreed to the published version of the manuscript.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Declarations

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki and it was approved by the Ethics Committee of the University of Tuebingen (Project Number 215/2020BO2).

Informed consent

Patient consent was waived due to the retrospective nature of the study and because only anonymous clinical data was analyzed.

Competing interests

The authors declare no conflict of interest.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Forsaa VA Lindtjorn B Kvaloy JT Epidemiology and morphology of full-thickness macular holes Acta Ophthalmol 2018 96 397 404 10.1111/aos.13618 29197164
Forsaa VA, Lindtjorn B, Kvaloy JT et al (2018) Epidemiology and morphology of full-thickness macular holes. Acta Ophthalmol 96:397–404. 10.1111/aos.1361829197164 10.1111/aos.13618
2. Eckardt C Eckardt U Groos S Removal of the internal limiting membrane in macular holes. Clinical and morphological findings Ophthalmologe 1997 94 545 551 10.1007/s003470050156 9376691
Eckardt C, Eckardt U, Groos S et al (1997) Removal of the internal limiting membrane in macular holes. Clinical and morphological findings. Ophthalmologe 94:545–551. 10.1007/s0034700501569376691 10.1007/s003470050156
3. Fung NSK Mak AKH Yiu R Treatment of large, chronic and persistent macular hole with internal limiting membrane transposition and tuck technique Int J Retina Vitreous 2020 6 3 10.1186/s40942-019-0206-7 32180996
Fung NSK, Mak AKH, Yiu R et al (2020) Treatment of large, chronic and persistent macular hole with internal limiting membrane transposition and tuck technique. Int J Retina Vitreous 6:3. 10.1186/s40942-019-0206-732180996 10.1186/s40942-019-0206-7
4. Kelly NE Wendel RT Vitreous surgery for idiopathic macular holes. Results of a pilot study Arch Ophthalmol 1991 109 654 659 10.1001/archopht.1991.01080050068031 2025167
Kelly NE, Wendel RT (1991) Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 109:654–659. 10.1001/archopht.1991.010800500680312025167 10.1001/archopht.1991.01080050068031
5. Michalewska Z Michalewski J Adelman RA Nawrocki J Inverted internal limiting membrane flap technique for large macular holes Ophthalmology 2010 117 2018 2025 10.1016/j.ophtha.2010.02.011 20541263
Michalewska Z, Michalewski J, Adelman RA, Nawrocki J (2010) Inverted internal limiting membrane flap technique for large macular holes. Ophthalmology 117:2018–2025. 10.1016/j.ophtha.2010.02.01120541263 10.1016/j.ophtha.2010.02.011
6. Morizane Y Shiraga F Kimura S Autologous transplantation of the internal limiting membrane for refractory macular holes Am J Ophthalmol 2014 157 861 869 10.1016/j.ajo.2013.12.028 24418265
Morizane Y, Shiraga F, Kimura S et al (2014) Autologous transplantation of the internal limiting membrane for refractory macular holes. Am J Ophthalmol 157:861–869. 10.1016/j.ajo.2013.12.02824418265 10.1016/j.ajo.2013.12.028
7. Grondin C Lorenzi U Beral L Successful Closure of a Large Full-Thickness Macular Hole Secondary to an Idiopathic Retinal Vasoproliferative Tumor Using the Inverted Internal Limiting Membrane Flap Technique Retin Cases Brief Rep 2022 16 490 493 10.1097/ICB.0000000000001015 32657849
Grondin C, Lorenzi U, Beral L et al (2022) Successful Closure of a Large Full-Thickness Macular Hole Secondary to an Idiopathic Retinal Vasoproliferative Tumor Using the Inverted Internal Limiting Membrane Flap Technique. Retin Cases Brief Rep 16:490–493. 10.1097/ICB.000000000000101532657849 10.1097/ICB.0000000000001015
8. Stalmans P Benz MS Gandorfer A Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes N Engl J Med 2012 367 606 615 10.1056/NEJMoa1110823 22894573
Stalmans P, Benz MS, Gandorfer A et al (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 367:606–615. 10.1056/NEJMoa111082322894573 10.1056/NEJMoa1110823
9. Liang X Liu W Characteristics and Risk Factors for Spontaneous Closure of Idiopathic Full-Thickness Macular Hole J Ophthalmol 2019 2019 4793764 10.1155/2019/4793764 31001430
Liang X, Liu W (2019) Characteristics and Risk Factors for Spontaneous Closure of Idiopathic Full-Thickness Macular Hole. J Ophthalmol 2019:4793764. 10.1155/2019/479376431001430 10.1155/2019/4793764
10. Elhusseiny AM Smiddy WE Flynn HW Schwartz SG Case Series of Recurring Spontaneous Closure of Macular Hole Case Rep Ophthalmol Med 2019 2019 2398342 10.1155/2019/2398342 31316850
Elhusseiny AM, Smiddy WE, Flynn HW, Schwartz SG (2019) Case Series of Recurring Spontaneous Closure of Macular Hole. Case Rep Ophthalmol Med 2019:2398342. 10.1155/2019/239834231316850 10.1155/2019/2398342
11. Gonzalez-Cortes JH Toledo-Negrete JJ Bages-Rousselon Y Spontaneous Closure of Simultaneous Idiopathic Macular Holes Documented by Spectral-Domain Optical Coherence Tomography Retin Cases Brief Rep 2021 15 27 30 10.1097/ICB.0000000000000749 29847534
Gonzalez-Cortes JH, Toledo-Negrete JJ, Bages-Rousselon Y et al (2021) Spontaneous Closure of Simultaneous Idiopathic Macular Holes Documented by Spectral-Domain Optical Coherence Tomography. Retin Cases Brief Rep 15:27–30. 10.1097/ICB.000000000000074929847534 10.1097/ICB.0000000000000749
12. Ozgonul C Besirli CG Macular hole closure following spontaneous release of vitreomacular traction BMJ Case Rep 2017 2017 bcr2016218547 10.1136/bcr-2016-218547 28249883
Ozgonul C, Besirli CG (2017) Macular hole closure following spontaneous release of vitreomacular traction. BMJ Case Rep 2017:bcr2016218547. 10.1136/bcr-2016-21854728249883 10.1136/bcr-2016-218547
13. Morawski K Jedrychowska-Jamborska J Kubicka-Trzaska A Romanowska-Dixon B THE ANALYSIS OF SPONTANEOUS CLOSURE MECHANISMS AND REGENERATION OF RETINAL LAYERS OF A FULL-THICKNESS MACULAR HOLE: Relationship with Visual Acuity Improvement Retina 2016 36 2132 2139 10.1097/IAE.0000000000001074 27172096
Morawski K, Jedrychowska-Jamborska J, Kubicka-Trzaska A, Romanowska-Dixon B (2016) THE ANALYSIS OF SPONTANEOUS CLOSURE MECHANISMS AND REGENERATION OF RETINAL LAYERS OF A FULL-THICKNESS MACULAR HOLE: Relationship with Visual Acuity Improvement. Retina 36:2132–2139. 10.1097/IAE.000000000000107427172096 10.1097/IAE.0000000000001074
14. Hikichi T Yoshida A Akiba J Trempe CL Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes Br J Ophthalmol 1995 79 517 520 10.1136/bjo.79.6.517 7626565
Hikichi T, Yoshida A, Akiba J, Trempe CL (1995) Natural outcomes of stage 1, 2, 3, and 4 idiopathic macular holes. Br J Ophthalmol 79:517–520. 10.1136/bjo.79.6.5177626565 10.1136/bjo.79.6.517
15. Kim JW Freeman WR Azen SP Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group Am J Ophthalmol 1996 121 605 614 10.1016/s0002-9394(14)70625-7 8644802
Kim JW, Freeman WR, Azen SP et al (1996) Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group. Am J Ophthalmol 121:605–614. 10.1016/s0002-9394(14)70625-78644802 10.1016/s0002-9394(14)70625-7
16. Garg ABB Yan P Spontaneous Closure of an Idiopathic Full-Thickness Macular Hole: A Literature Review J VitreoRetinal Dis 2022 6 381 390 10.1177/24741264211049873
Garg ABB, Yan P (2022) Spontaneous Closure of an Idiopathic Full-Thickness Macular Hole: A Literature Review. J VitreoRetinal Dis 6:381–390. 10.1177/2474126421104987310.1177/24741264211049873
17. Privat E Tadayoni R Gaucher D Residual defect in the foveal photoreceptor layer detected by optical coherence tomography in eyes with spontaneously closed macular holes Am J Ophthalmol 2007 143 814 819 10.1016/j.ajo.2006.12.039 17362861
Privat E, Tadayoni R, Gaucher D et al (2007) Residual defect in the foveal photoreceptor layer detected by optical coherence tomography in eyes with spontaneously closed macular holes. Am J Ophthalmol 143:814–819. 10.1016/j.ajo.2006.12.03917362861 10.1016/j.ajo.2006.12.039
18. Sugiyama A Imasawa M Chiba T Iijima H Reappraisal of spontaneous closure rate of idiopathic full-thickness macular holes Open Ophthalmol J 2012 6 73 74 10.2174/1874364101206010073 22934124
Sugiyama A, Imasawa M, Chiba T, Iijima H (2012) Reappraisal of spontaneous closure rate of idiopathic full-thickness macular holes. Open Ophthalmol J 6:73–74. 10.2174/187436410120601007322934124 10.2174/1874364101206010073
19. Nawrocka Vel Michalewska ZA Nawrocka Z Nawrocki J Spontaneous Closure of Full-Thickness Macular Holes Ophthalmologica 2022 245 49 58 10.1159/000516768 33915537
Nawrocka Vel Michalewska ZA, Nawrocka Z, Nawrocki J (2022) Spontaneous Closure of Full-Thickness Macular Holes. Ophthalmologica 245:49–58. 10.1159/00051676833915537 10.1159/000516768
20. Murphy DC Al-Zubaidy M Lois N The Effect of Macular Hole Duration on Surgical Outcomes: An Individual Participant Data Study of Randomized Controlled Trials Ophthalmology 2022 10.1016/j.ophtha.2022.08.028 36058348
Murphy DC, Al-Zubaidy M, Lois N et al (2022) The Effect of Macular Hole Duration on Surgical Outcomes: An Individual Participant Data Study of Randomized Controlled Trials. Ophthalmology. 10.1016/j.ophtha.2022.08.02836058348 10.1016/j.ophtha.2022.08.028
21. Steel DH Donachie PHJ Aylward GW Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort Eye (Lond) 2021 35 316 325 10.1038/s41433-020-0844-x 32231259
Steel DH, Donachie PHJ, Aylward GW et al (2021) Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort. Eye (Lond) 35:316–325. 10.1038/s41433-020-0844-x32231259 10.1038/s41433-020-0844-x
22. Duker JS Kaiser PK Binder S The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole Ophthalmology 2013 120 2611 2619 10.1016/j.ophtha.2013.07.042 24053995
Duker JS, Kaiser PK, Binder S et al (2013) The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology 120:2611–2619. 10.1016/j.ophtha.2013.07.04224053995 10.1016/j.ophtha.2013.07.042
23. Dugel PU Tolentino M Feiner L Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial Ophthalmology 2016 123 2232 2247 10.1016/j.ophtha.2016.06.043 27499517
Dugel PU, Tolentino M, Feiner L et al (2016) Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial. Ophthalmology 123:2232–2247. 10.1016/j.ophtha.2016.06.04327499517 10.1016/j.ophtha.2016.06.043
24. Haller JA Stalmans P Benz MS Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials Ophthalmology 2015 122 117 122 10.1016/j.ophtha.2014.07.045 25240630
Haller JA, Stalmans P, Benz MS et al (2015) Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials. Ophthalmology 122:117–122. 10.1016/j.ophtha.2014.07.04525240630 10.1016/j.ophtha.2014.07.045
25. Mori T Kitamura S Sakaguchi H Two cases of repeating recurrences and spontaneous closures of macular holes in vitrectomized eyes Jpn J Ophthalmol 2018 62 467 472 10.1007/s10384-018-0596-3 29748866
Mori T, Kitamura S, Sakaguchi H et al (2018) Two cases of repeating recurrences and spontaneous closures of macular holes in vitrectomized eyes. Jpn J Ophthalmol 62:467–472. 10.1007/s10384-018-0596-329748866 10.1007/s10384-018-0596-3
26. Hayashi I Shinoda H Nagai N Retinal inflammation diagnosed as an idiopathic macular hole with multiple recurrences and spontaneous closures: A case report Medicine (Baltimore) 2019 98 e14230 10.1097/MD.0000000000014230 30681603
Hayashi I, Shinoda H, Nagai N et al (2019) Retinal inflammation diagnosed as an idiopathic macular hole with multiple recurrences and spontaneous closures: A case report. Medicine (Baltimore) 98:e14230. 10.1097/MD.000000000001423030681603 10.1097/MD.0000000000014230
27. Lee J Nguyen VQ Doss MK Eller AW Spontaneous closure of a chronic full thickness macular hole after failed surgery Am J Ophthalmol Case Rep 2019 13 59 61 10.1016/j.ajoc.2018.12.006 30582073
Lee J, Nguyen VQ, Doss MK, Eller AW (2019) Spontaneous closure of a chronic full thickness macular hole after failed surgery. Am J Ophthalmol Case Rep 13:59–61. 10.1016/j.ajoc.2018.12.00630582073 10.1016/j.ajoc.2018.12.006
28. Kokame GT McCauley MB Spontaneous reopening of a spontaneously closed macular hole Am J Ophthalmol 2002 133 280 282 10.1016/s0002-9394(01)01306-x 11812442
Kokame GT, McCauley MB (2002) Spontaneous reopening of a spontaneously closed macular hole. Am J Ophthalmol 133:280–282. 10.1016/s0002-9394(01)01306-x11812442 10.1016/s0002-9394(01)01306-x
29. Ishida M Takeuchi S Okisaka S Optical coherence tomography images of idiopathic macular holes with spontaneous closure Retina 2004 24 625 628 10.1097/00006982-200408000-00024 15300092
Ishida M, Takeuchi S, Okisaka S (2004) Optical coherence tomography images of idiopathic macular holes with spontaneous closure. Retina 24:625–628. 10.1097/00006982-200408000-0002415300092 10.1097/00006982-200408000-00024
30. Parikh P Day Ghafoori S Dixit L Harper CA 3rd Spontaneous Closure of a Macular Hole Resulting from Yag Laser Capsulotomy in a 13-Year-Old Girl Retin Cases Brief Rep 2021 15 640 642 10.1097/ICB.0000000000000871 30932992
Parikh P, Day Ghafoori S, Dixit L, Harper CA 3rd (2021) Spontaneous Closure of a Macular Hole Resulting from Yag Laser Capsulotomy in a 13-Year-Old Girl. Retin Cases Brief Rep 15:640–642. 10.1097/ICB.000000000000087130932992 10.1097/ICB.0000000000000871
31. Alsakran WA Alsulaiman SM Ghazi NG Delayed spontaneous closure of blue laser-induced full thickness macular hole Am J Ophthalmol Case Rep 2019 13 154 156 10.1016/j.ajoc.2019.01.003 30766936
Alsakran WA, Alsulaiman SM, Ghazi NG (2019) Delayed spontaneous closure of blue laser-induced full thickness macular hole. Am J Ophthalmol Case Rep 13:154–156. 10.1016/j.ajoc.2019.01.00330766936 10.1016/j.ajoc.2019.01.003
32. Bhojwani D Vasavada S Sudhalkar A Acute full-thickness macular hole after uneventful femtosecond-assisted cataract surgery and its spontaneous closure Indian J Ophthalmol 2018 66 848 849 10.4103/ijo.IJO_1177_17 29785998
Bhojwani D, Vasavada S, Sudhalkar A et al (2018) Acute full-thickness macular hole after uneventful femtosecond-assisted cataract surgery and its spontaneous closure. Indian J Ophthalmol 66:848–849. 10.4103/ijo.IJO_1177_1729785998 10.4103/ijo.IJO_1177_17
33. Llop SM Gonzalez E Emanuelli A Spontaneous Closure of a Full-Thickness Macular Hole Secondary to Irvine-Gass Syndrome Retin Cases Brief Rep 2017 11 243 245 10.1097/ICB.0000000000000331 27243783
Llop SM, Gonzalez E, Emanuelli A (2017) Spontaneous Closure of a Full-Thickness Macular Hole Secondary to Irvine-Gass Syndrome. Retin Cases Brief Rep 11:243–245. 10.1097/ICB.000000000000033127243783 10.1097/ICB.0000000000000331
34. Bonnin N Cornut PL Chaise F Spontaneous closure of macular holes secondary to posterior uveitis: case series and a literature review J Ophthalmic Inflamm Infect 2013 3 34 10.1186/1869-5760-3-34 23514634
Bonnin N, Cornut PL, Chaise F et al (2013) Spontaneous closure of macular holes secondary to posterior uveitis: case series and a literature review. J Ophthalmic Inflamm Infect 3:34. 10.1186/1869-5760-3-3423514634 10.1186/1869-5760-3-34
35. Pascual-Camps I Barranco-Gonzalez H Dolz-Marco R Gallego-Pinazo R Spontaneous closure of traumatic macular hole in a pediatric patient J AAPOS 2017 21 414 416 10.1016/j.jaapos.2017.04.009 28713057
Pascual-Camps I, Barranco-Gonzalez H, Dolz-Marco R, Gallego-Pinazo R (2017) Spontaneous closure of traumatic macular hole in a pediatric patient. J AAPOS 21:414–416. 10.1016/j.jaapos.2017.04.00928713057 10.1016/j.jaapos.2017.04.009
36. Sokol JT Schechet SA Komati R Macular Hole Closure with Medical Treatment Ophthalmol Retina 2021 5 711 713 10.1016/j.oret.2020.11.018 33338669
Sokol JT, Schechet SA, Komati R et al (2021) Macular Hole Closure with Medical Treatment. Ophthalmol Retina 5:711–713. 10.1016/j.oret.2020.11.01833338669 10.1016/j.oret.2020.11.018
37. Bringmann A Duncker T Jochmann C Spontaneous closure of small full-thickness macular holes: Presumed role of Muller cells Acta Ophthalmol 2020 98 e447 e456 10.1111/aos.14289 31654489
Bringmann A, Duncker T, Jochmann C et al (2020) Spontaneous closure of small full-thickness macular holes: Presumed role of Muller cells. Acta Ophthalmol 98:e447–e456. 10.1111/aos.1428931654489 10.1111/aos.14289
38. Okubo A Unoki K Yamakiri K Early structural changes during spontaneous closure of idiopathic full-thickness macular hole determined by optical coherence tomography: a case report BMC Res Notes 2013 6 396 10.1186/1756-0500-6-396 24083650
Okubo A, Unoki K, Yamakiri K et al (2013) Early structural changes during spontaneous closure of idiopathic full-thickness macular hole determined by optical coherence tomography: a case report. BMC Res Notes 6:396. 10.1186/1756-0500-6-39624083650 10.1186/1756-0500-6-396
39. Guyer DR Green WR de Bustros S Fine SL Histopathologic features of idiopathic macular holes and cysts Ophthalmology 1990 97 1045 1051 10.1016/s0161-6420(90)32465-x 2402416
Guyer DR, Green WR, de Bustros S, Fine SL (1990) Histopathologic features of idiopathic macular holes and cysts. Ophthalmology 97:1045–1051. 10.1016/s0161-6420(90)32465-x2402416 10.1016/s0161-6420(90)32465-x
